Generics, APIs, Formulation
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
315
NCT04699656
Plazomicin Study in ESRD Patients Receiving IHD
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 5, 2021
Completion: Jun 9, 2021
NCT07083089
Early Stage of Alzheimer's and Parkinson's Diseases, HearIng Relevance (SAPHIR)
Phase: N/A
Start: Mar 24, 2025
Completion: Dec 31, 2026
Loading map...